Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke
Condition: Acute Ischemic Stroke Interventions: Drug: Xueshuantong lyophilized powder; Drug: Xueshuantong lyophilized powder Placebo (Extremely low dose of Xueshuantong lyophilized powder); Other: Guidelines-based standard care Sponsors: Dongzhimen Hospital, Beijing; Tianjin University of Traditional Chinese Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials